Caffeine Completed Phase 1 Trials for Pharmacokinetics of Repaglinide / Pharmacokinetics of Caffeine / Healthy Volunteers Basic Science

IndicationsStatusPurposePhase
CompletedBasic Science1
clinicaltrials.gov IdentifierTitleDrugs
NCT02128321A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of Repaglinide and Caffeine
NCT02361619Dabigatran in an Interaction Probe Drug Cocktail
NCT02109497Phase 1 Study to Determine the Effects of PBT2 on the Pharmacokinetic Profile of Caffeine
NCT00824057Effect of Multiple Doses of AZD6280 on the Pharmacokinetics of Midazolam (CYP3A4) and Caffeine (CYP1A2)
NCT01934569Drug-Drug Interaction Study With PF-05089771